Doppler evaluation of erectile dysfunction - Part 1

International Journal of Impotence Research

Volumn 19, Issue 1, 2007, Pages 37-42

  Golijanin, D ^a   Singer, E ^a   Davis, R ^a   Bhatt, S ^a   Seftel, A ^b   Dogra, V ^a,c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Color Doppler; Erectile dysfunction; Erection; Impotence; Penis; Ultrasound

Indexed keywords

PAPAVERINE; PHENTOLAMINE; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1;

AGE DISTRIBUTION; ARTERY BLOOD FLOW; BLOOD FLOW VELOCITY; CARDIOVASCULAR RISK; COLOR ULTRASOUND FLOWMETRY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; ERECTILE DYSFUNCTION; HUMAN; IMAGE QUALITY; MEDICAL EXAMINATION; PATIENT POSITIONING; PENIS ERECTION; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR;

ADULT; AGED; AGING; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PENILE ERECTION; PENIS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 33846076782     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901477     Document Type: Review

References (42)

1. NIH Consensus Conference. Impotence. NIH consensus development panel on impotence. JAMA 1993; 270: 83-90.
2. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinmann KP, McKinlay JB. Incidence of erectile dysfunction in men 40-69 years old. Longitudinal Results from the Massachusetts Male Aging Study. J Urol 2000; 163: 460-463.
3. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
4. Padma-Nathan H. Diagnostic and treatment strategies for erectile dysfunction: the 'process of care' model. Int J Impot Res 2000; 12(Suppl 4): S119-S121.
5. Gingell C, Wright P, Barnes T, Dean J, Dinsmore W, Eardley I et al. Guidance on the management of erectile dysfunction in primary care. Prescriber 1999; (Suppl 5): 1-15.
6. Jardin A, Wagner G, Khoury S. Recommendations of the 1st International Consultation on Erectile Dysfunction. In: Jardin A, Wagner G, Khoury S, Giuliano F, Padma-Nathan H, Rosen R (eds). Erectile Dysfunction. Plymbridge Distributors Ltd.: Plymouth, UK, 2000, pp 711-726.
7. Wespes E, Amar E, Hatzichristou D, Montorsi F, Pryor J, Vardi Y. European association of urology. Guidelines on erectile dysfunction. Eur Urol 2002; 41: 1-5.
8. Levine LA. Diagnosis and treatment of erectile dysfunction. Am J Med 2000; 109(Suppl 9A): 3S-12S discussion 29S-30S).
9. Levine LA, Kloner RA. Importance of asking questions about erectile dysfunction. Am J Cardiol 2000; 86: 1210-1213.
10. Falk RH. The cardiovascular response to sexual activity: do we know enough? Clin Cardiol 2001; 24: 271-275.
11. Speel TGW, Bleumer I, Diemont WL, van der Maas MC, Wijkstra H, Meuleman EJ. The value of sildenafil as mode of stimulation in pharmaco-penile duplex ultrasonography. Int J Impot Res 2001; 13: 189-191.
12. Barrett-Connor E. Cardiovascular risk stratification and cardiovascular risk factors associated with erectile dysfunction: assessing cardiovascular risk in men with erectile dysfunction. Clin Cardiol 2004; 27(4, Suppl 1): I8-I13.
13. Shamloul R, Ghanem HM, Salem A, Elnashaar A, Elnaggar W, Darwish H et al. Correlation between penile duplex findings and stress electrocardiography in men with erectile dysfunction. Int J Impot Res 2004; 16: 235-237.
14. El-Sakka AI, Morsy AM, Fagih BI, Nassar AH. Coronary artery risk factors in patients with erectile dysfunction. J Urol 2004; 172: 251-254.
15. Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. Am J Cardiol 2000; 86(Suppl): 41F-45F.
16. Montorsi P, Ravagnani PM, Galli S, Briganti A, Salonia A, Dehó F et al. Association between erectile dysfunction and coronary artery disease: a case report study. J Sex Med 2005; 2: 575.
17. Enbergs A, Bürger R, Reinecke H, Borggrefe M, Breithardt G, Kerber S. Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease: angiographic analysis of subjects aged 40-70 years referred for catheter ablation therapy. Eur Heart J 2000; 21: 45-52.
18. El-Sakka AI, Morsy AM. Screening for ischemic heart disease in patients with erectile dysfunction: role of penile Doppler ultrasonography. Urology 2004; 64: 346-350.
19. Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004; 110: 22-26.
20. Meuleman EJ, Diemont WL. Investigation of erectile dysfunction. Diagnostic testing for vascular factors in erectile dysfunction. Urol Clin N Am 1995; 22: 803-819.
21. Kayigil O, Metin A. Relaxation degree: a new concept in erectile dysfunction. Int Urol Nephrol 2001; 33: 391-394.
22. Lue TF, Hricak H, Marich KW, Tanagho EA. Vasculogenic impotence evaluated by high resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology 1985; 155: 777-781.
23. Virag R, Shoukry K, Floresco J, Nollet F, Greco E. Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases. J Urol 1991; 145: 287-292.
24. Montorsi F, Guazzoni G, Bergamaschi F, Dodesini A, Rigatti P, Pizzini G et al. Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence. Urology 1993; 42: 554-558.
25. Heaton JP, Lording D, Liu SN, Litonjua AD, Guangwei L, Kim SC et al. Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men. Int J Impot Res 2001; 13: 317-321.
26. Montorsi F, Guazzoni G, Barbierir L, Ferini-Strambi L, Iannacone S, Calori G et al. Genital plus audiovisual sexual stimulation following intracavernous vasoactive injection versus re-dosing for erectile dysfunction: results of a prospective study. J Urol 1998; 159: 113-115.
27. Park K, Kwon DD, Oh BR, Ryu SB, Park YI. Efficacy of virtual glasses in audio-visual sexual stimulation during penile color duplex Doppler ultrasonography. Eur Urol 2002; 41: 62-65.
28. Speel TG, Bleumer I, Diemont WL, van der Maas MC, Wijkstra H, Meuleman EJ. The value of sildenafil as mode of stimulation in pharmaco-penile duplex ultrasonography. Int J Impot Res 2001; 13: 189-191.
29. Bacar MM, Batislam E, Altinok D, Yilmaz E, Bacar H. Sildenafil citrate for penile hemodynamic determination: an alternative to intracavernosal agents in Doppler ultrasound evaluation of erectile dysfunction. Urology 2001; 57: 623-626 (discussion 626-662).
30. Bhargava R, Srivastava DN, Thulkar S, Kropman RF, Schiper J, van Oostayen JA et al. The value of increased end diastolic velocity during penile duplex sonography in relation to pathological venous leakage in erectile dysfunction. J Urol 1992; 148: 314-317.
31. Furst G, Muller-Matheis V, Cohnen M, Trautner C, Haastert B, Saleh A et al. Venous incompetence in erectile dysfunction: evaluation with colour coded duplex sonography and cavernosometry/graphy. Eur Radiol 1999; 9: 35-41.
32. Lue TF, Mueller SC, Jow YR, Hwang TI. Functional evaluation of penile arteries with duplex ultrasound in vasodilator-induced erection. Urol Clin N Am 1989; 16: 799-807.
33. Quam JP, King BF, James EM, Lewis RW, Brakke DM, Ilstrup DM et al. Duplex and color Doppler sonographic evaluation of vasculogenic impotence. Am J Roentgenol 1989; 153: 1141-1147.
34. Chiang PH, Chiang CP, Wu CC, Wang CJ, Chen MT, Huang CH et al. Colour duplex sonography in the assessment of impotence. Br J Urol 1991; 68: 181-186.
35. Pickard RS, Powell PH, Zar MA. The effect of inhibitors of nitric oxide biosynthesis and cyclic GMP formation on nerve-evoked relaxation of human cavernosal smooth muscle. Br J Pharmacol 1991; 104: 755-759.
36. Benson CB, Doubilet PM, Vickers Jr MA. Sonography of the penis. Ultrasound Q 1991; 9: 89-109.
37. Lee B, Sikka SC, Randrup ER, Villemarette P, Baum N, Hower JF et al. Standardization of penile blood flow parameters in normal men using intracavernous prostaglandin E1 and visual sexual stimulation. J Urol 1993; 149: 49-52.
38. Karadeniz T, Topsakal M, Aydogmus A, Gulgun C, Aytekin Y, Basak D. Correlation of ultrastructural alterations in cavernous tissue with the clinical diagnosis vasculogenic impotence. Urol Int 1996; 57: 58-61.
39. Golubinski AJ, Sikorski A. Usefulness of power Doppler ultrasonography in evaluating erectile dysfunction. BJU Int 2002; 89: 779-782.
40. Speel TG, van Langen H, Wijkstra H, Meuleman EJ. Penile duplex pharmacoultrasonography revisited: revalidation of the parameters of the cavernous arterial response. J Urol 2003; 169: 216-220.
41. Cornud F, Amar E, Hamida K, Thiounn N, Hea Leanon O, Moreau JF. Imaging in male hypofertility and impotence. Br J Urol Int 2000; 86(Suppl 1): 153-163.
42. Kropman RF, Schiper J, van Oostayen JA, Lycklama A, Nijeholt AA, Meinhardt W. The value of increased end diastolic velocity during penile duplex sonography in relation to pathological venous leakage in erectile dysfunction. J Urol 1992; 148: 314-317.